Laboratory Indicators of Active Bleeding
Repeated hemoglobin (Hb) and hematocrit (Hct) measurements are the primary laboratory markers for detecting bleeding, as a single initial value in the normal range can mask early-phase hemorrhage. 1
Core Laboratory Tests for Bleeding Detection
Hemoglobin and Hematocrit Monitoring
Serial Hb/Hct measurements are essential because initial values may appear falsely normal before plasma equilibration occurs, typically masking acute blood loss in the first 30-60 minutes after bleeding begins 1, 2
Hemoglobin drops can occur within minutes of injury in actively bleeding patients, with Hb ≤10 g/dL measured within 30 minutes of arrival correctly identifying significant bleeding in 87% of trauma patients 2
A decline in Hb of ≥2 g/dL between measurements strongly suggests ongoing hemorrhage, particularly when accounting for fluid resuscitation volumes 3, 4
Low initial Hct or Hb levels closely correlate with hemorrhagic shock, with Hb <80 g/L (8 g/dL) in pelvic trauma patients associated with non-survival 1
Complete Blood Count (CBC)
Obtain CBC with platelet count to assess for anemia (low Hb/Hct) and thrombocytopenia, both of which indicate either blood loss or impaired hemostasis 5, 6
Leukocytosis ≥11,000/mm³ is an independent predictor of significant hemoglobin drops (≥2 g/dL), suggesting inflammatory response to bleeding or tissue injury 3
Coagulation Studies
Prothrombin time (PT) or INR and activated partial thromboplastin time (aPTT) should be obtained in bleeding patients to detect coagulopathy that may worsen hemorrhage 5, 7, 6
Platelet count, PT/INR, and aPTT form the basic coagulation panel, with additional tests including fibrinogen level, thrombin time, and D-dimers when coagulopathy is suspected 7, 8
Fibrinogen levels <1.5 g/L indicate consumptive coagulopathy and predict ongoing bleeding requiring replacement therapy 9
Additional Laboratory Markers
Metabolic Indicators of Hemorrhagic Shock
Lactate >2 mmol/L measured via venous blood gas indicates tissue hypoperfusion from hemorrhagic shock 9
Base deficit and pH correlate with severity of blood loss, with worsening base deficit and decreasing pH associated with lower Hb levels and increased transfusion requirements 2
Blood urea nitrogen (BUN) and creatinine should be checked to assess renal perfusion and guide fluid resuscitation 5
Specialized Testing for Bleeding Disorders
Von Willebrand factor (VWF) testing includes VWF antigen (VWF:Ag), VWF ristocetin cofactor activity (VWF:RCo), and factor VIII coagulant activity (FVIII) when mucocutaneous bleeding history is strong 10, 6
A VWF:RCo to VWF:Ag ratio <0.5-0.7 suggests von Willebrand disease, though this is rarely the cause of intracranial hemorrhage or severe bleeding 11, 10
Critical Interpretation Considerations
Timing and Serial Measurements
The key pitfall is relying on a single initial Hb/Hct value, which frequently appears normal despite significant ongoing bleeding because plasma equilibration requires time and is confounded by crystalloid resuscitation 1, 2
Point-of-care Hb measured prehospital has modest predictive ability (AUC 0.72) with best cutoffs of 12 g/dL for women and 13 g/dL for men, while hospital admission Hb has superior predictive ability (AUC 0.92) with cutoffs of 10 g/dL for women and 12 g/dL for men 4
The magnitude of Hb drop between prehospital and hospital measurements (DeltaPOC-Hb ≥2 g/dL) predicts significant hemorrhage better than shock index alone, even accounting for fluid resuscitation volumes 4
False Results and Confounders
Prolonged PT and aPTT from parenchymal liver damage in abusive head trauma should not automatically be interpreted as primary bleeding disorders 11
Hemodilution from crystalloid resuscitation artificially lowers Hb/Hct and can mask the true degree of blood loss or exaggerate it depending on timing 1, 2, 12
VWF is an acute phase reactant that can be falsely elevated by stress, inflammation, pregnancy, or estrogen use, requiring up to 3 repeat measurements for reliable results 10, 6